Closing Indices

 31st December 2021 

Bse Sensex Closed @ 58253.82 ✅ 459.50 Points 

Nse Nifty Closed @ 17354.05 ✅ 150.10 Points 

Bank Nifty Closed 35481.70 ✅ 418.10 Points 

India VIX Closed @ 16.2225 ❌ 0.3425 Points.

Weekly 27th -- 31st December 2021 

Bse Sensex Closed @ 58253.82 ✅ 1129.51 Points 

Nse Nifty Closed @ 17354.05 ✅ 350.30 Points 

Bank Nifty Closed 35481.70 ✅ 624.65 Points 

India VIX Closed @ 16.2225 ✅ 0.0750 Points.

December Monthly 2021 

Bse Sensex Closed @ 58253.82 ✅ 1188.95 Points 

Nse Nifty Closed @ 17354.05 ✅ 370.85 Points 

Bank Nifty Closed 35481.70 ❌ 213.60 Points 

India VIX Closed @ 16.2225 ❌ 4.9450 Points.

Year 2021 

Bse Sensex Closed @ 58253.82 ✅ 26989.32 Points 

Nse Nifty Closed @ 17354.05 ✅ 3372.30 Points 

Bank Nifty Closed 35481.70 ❌ 12269.63 Points 

India VIX Closed @ 16.2225 ❌ 4.8725 Points.

New Listing

 New Listings : CMS INFO SYSTEMS LIMITED

Abb : CMSINFO

Segment : BSE / NSE

Code : 543441 / 7603

Group : B / EQ

Isin : INE925R01014

FV : 10.00

ML : 1

Issue Price : 216 / - 

In News

Stocks in News

CMS Info Systems: The company will make a debut on the bourses on December 31. The final issue price is fixed at Rs 216 per share. 

PB Fintech: The company approved investment of up to Rs 700 crore in one or more tranches in subsidiary Policybazaar Insurance Brokers Private Limited during FY22 and FY23, and up to Rs 299.99 crore in subsidiary Paisabazaar Marketing and Consulting Private Limited. 

Power Grid Corporation of India: The company has approved investment proposal for 'expansion of POWERGRID telecom into data centre business and to establish a data centre at Manesar at an estimated cost of around Rs 322 crore. 

Sterling and Wilson Renewable Energy: The company has approved the preferential allotment of 2.93 crore equity shares, to RNESL at a price of Rs 375 per share, aggregating to Rs 1,099,99 crore. Post the allotment, RNESL will hold 15.46% stake in the company. 

JSW Energy: Life Insurance Corporation of India acquired 2.01% stake in the company via open market transactions, increasing shareholding to 9.01% from 7.00% earlier. 

Biocon: Subsidiary Biocon Biologics' partner Viatris won US Court decisions on Sanofi appeals for Lantus device patents.